Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ACACB | O00763 | 5/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24568233 | 0.79 | ACACB (0.47) | KMT2AACACBABL1HDAC1KIF11 | |
| SCHEMBL2780654 | 0.79 | — | — | |
| SCHEMBL24568381 | 0.76 | ACACB (0.55) | KMT2AACACBKIF11 | |
| SCHEMBL343489 | 0.75 | — | — | |
| SCHEMBL21286901 | 0.75 | — | — | |
| SCHEMBL28187036 | 0.75 | — | — | |
| SCHEMBL5608437 | 0.75 | KMT2A (0.41) | KMT2AACACBABL1IDO1TDO2 | |
| SCHEMBL5140577 | 0.74 | KMT2A (0.51) | KMT2AACACBABL1IDO1TDO2 | |
| SCHEMBL2146814 | 0.74 | KMT2A (0.49) | KMT2AACACBABL1IDO1TDO2 | |
| SCHEMBL24567564 | 0.74 | ACACB (0.53) | KMT2AACACBHDAC1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110152097-A1 | Active Compound Combinations | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
| EP-2263463-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-22 | — | — | EP | disclosed |
| EP-2263462-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-22 | — | — | EP | disclosed |
| EP-2260709-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-2260710-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-2260711-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-2258197-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2258198-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2258196-A2 | Combination of active agents | Bayer CropScience AG (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2255653-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2255652-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2255649-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2255645-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2255651-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2255648-A2 | Agent combinations | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2253213-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-11-24 | — | — | EP | disclosed |
| EP-2253210-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-11-24 | — | — | EP | disclosed |
| EP-2253211-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-11-24 | — | — | EP | disclosed |
| EP-2253212-A1 | Agent combinations | Bayer CropScience AG (DE) | 2010-11-24 | — | — | EP | disclosed |
| EP-2132989-A2 | Agent combinations | Bayer CropScience AG (DE) | 2009-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152097-A1 | Active Compound Combinations | AGXT, GLUL, GMNN | KMT2A 263/4885ACACB 3442/4885ABL1 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.